CSIMarket


Abbott Laboratories  (ABT)
Other Ticker:  
 

Abbott Laboratories

ABT's Fundamental analysis








Looking into Abbott Laboratories growth rates, revenue grew by 13.76 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 674

Major Pharmaceutical Preparations industry recorded growth of revenues by 19.44 %

Abbott Laboratories's net income grew by 36.48 % in I. Quarter 2022 year on year, above company average,

More on ABT's Growth


Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 0.74 Abbott Laboratories realized cash outflow of $ -0.21per share in trailing twelve-month period.
Company
25.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.3.


More on ABT's Valuation
 
 Total Debt (Millions $) 17,090
 Dividend TTM ($) 1.81 $
 Dividend Yield TTM (%) 1.69 %
 Revenue/Employee (TTM) $ 416,019
 Net Income/Employee (TTM) $ 72,196
 Receivable Turnover (TTM) 6.8
 Tangible Book Value (Per Share $) 0.13

Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 0.74 Abbott Laboratories realized cash outflow of $ -0.21per share in trailing twelve-month period.
Company
25.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.3.

Abbott Laboratories Price to Book Ratio is at 5.53 lower than Indusry Avg. of 1262.65. and higher than S&P 500 Avg. of -0.01

More on ABT's Valuation

  Market Capitalization (Millions $) 196,992
  Shares Outstanding (Millions) 1,775
  Employees 107,000
  Revenues (TTM) (Millions $) 44,514
  Net Income (TTM) (Millions $) 7,725
  Cash Flow (TTM) (Millions $) -379
  Capital Exp. (TTM) (Millions $) -1,809
  Total Debt (Millions $) 17,090
  Dividend TTM ($) 1.81 $
  Dividend Yield TTM (%) 1.69 %
  Revenue/Employee (TTM) $ 416,019
  Net Income/Employee(TTM) $ 72,196
  Receivable Turnover Ratio (TTM) 6.8
  Tangible Book Value (Per Share $) 0.13

  Market Capitalization (Millions $) 196,992
  Shares Outstanding (Millions) 1,775
  Employees 107,000
  Revenues (TTM) (Millions $) 44,514
  Net Income (TTM) (Millions $) 7,725
  Cash Flow (TTM) (Millions $) -379
  Capital Exp. (TTM) (Millions $) -1,809


    ABT's Profitability Comparisons
Abbott Laboratories achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2022 to 24.48 % from 20.74 % in IV. Quarter.

Abbott Laboratories net profit margin of 20.57 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 61 in Healthcare sector and number 837 in S&P 500.


Profitability by Segment
Established Pharmaceutical Products 18.42 %
Nutritionals 25.66 %
Vascular 35.57 %
Diagnostics 26.56 %



  Ratio
   Capital Ratio (MRQ) 1.85
  Total Debt to Equity (MRQ) 0.48
  Tangible Leverage Ratio (MRQ) 133.17
  Asset Turnover Ratio (TTM) 0.6
  Inventory Turnover Ratio (TTM) 3.55



Abbott Laboratories achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2022 to 24.48 % from 20.74 % in IV. Quarter.

Abbott Laboratories net profit margin of 20.57 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 61 in Healthcare sector and number 837 in S&P 500.

More on ABT's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SAI's Profile

Stock Price

SAI's Financials

Business Description

Fundamentals

Charts & Quotes

SAI's News

Suppliers

SAI's Competitors

Customers & Markets

Economic Indicators

SAI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071